Akebia Therapeutics, Inc. (AKBA) Strengthens Vafseo Patent Protection Through 2036
TheFly reported on June 10 that AKBA strengthened the intellectual property protection for its flagship therapy, Vafseo (vadadustat), after receiving a new patent listing in the FDA’s Orange Book and...





